{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:49:58Z","timestamp":1779126598918,"version":"3.51.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1093\/humrep\/15.9.1965","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:40:04Z","timestamp":1027723204000},"page":"1965-1968","source":"Crossref","is-referenced-by-count":163,"title":["Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication"],"prefix":"10.1093","volume":"15","author":[{"given":"J.","family":"Itskovitz-Eldor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mannaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,9]]},"reference":[{"key":"key\n\t\t\t\t20170410034036_ALBANO-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Albano, C., Smitz, J., Camus, M. et al. (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil. Steril., 67, 917\u2013922.","DOI":"10.1016\/S0015-0282(97)81407-0"},{"key":"key\n\t\t\t\t20170410034036_CHILLIK-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Chillik, C.F., Itskovitz, J., Hahn, D.W. et al. (1987) Characterizing pituitary response to a gonadotropin-releasing hormone (GnRH) antagonist in monkeys: tonic follicle-stimulating hormone\/luteinizing hormone secretion versus acute GnRH challenge tests before, during, and after treatment. Fertil. Steril., 48, 480\u2013485.","DOI":"10.1016\/S0015-0282(16)59422-9"},{"key":"key\n\t\t\t\t20170410034036_DAMEWOOD-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Damewood, M.D., Shen, W., Zacur, H.A. et al. (1989) Disappearance of exogenously administered human chorionic gonadotropin. Fertil. Steril., 52, 398\u2013400.","DOI":"10.1016\/S0015-0282(16)60906-8"},{"key":"key\n\t\t\t\t20170410034036_EMPERAIRE-AND-RUFFIE-1991","doi-asserted-by":"crossref","unstructured":"Emperaire, J.C., and Ruffie, A. (1991) Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome. Hum. Reprod., 6, 506\u2013510.","DOI":"10.1093\/oxfordjournals.humrep.a137368"},{"key":"key\n\t\t\t\t20170410034036_FELBERBAUM-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Felberbaum, R.E., Reissmann, T., Kupker, W. et al. (1995) Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur. J. Obstet. Gynecol. Reprod. Biol., 61, 151\u2013155.","DOI":"10.1016\/0301-2115(95)02138-W"},{"key":"key\n\t\t\t\t20170410034036_GANIRELIX-DOSE-FINDING-STUDY-GROUP-1998","doi-asserted-by":"crossref","unstructured":"Ganirelix Dose-Finding Study Group (1998) A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum. Reprod., 13, 3023\u20133031.","DOI":"10.1093\/humrep\/13.11.3023"},{"key":"key\n\t\t\t\t20170410034036_GOLAN-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Golan, A., Ron-El, R., Herman, A. et al. (1989) Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv., 44, 430\u2013440.","DOI":"10.1097\/00006254-198906000-00004"},{"key":"key\n\t\t\t\t20170410034036_GONEN-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Gonen, Y., Balakiar, H., Powell, W. and Casper, R.F. (1990) Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J. Clin. Endocrinol. Metab., 71, 918\u2013922.","DOI":"10.1210\/jcem-71-4-918"},{"key":"key\n\t\t\t\t20170410034036_IMOEDEMHE-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Imoedemhe, D.A.G., Chan, R.C.W., Sigue, A.B. et al. (1991) A new approach to the management of patients at risk of ovarian hyperstimulation in an in-vitro fertilization programme. Hum. Reprod., 6, 1088\u20131091","DOI":"10.1093\/oxfordjournals.humrep.a137489"},{"key":"key\n\t\t\t\t20170410034036_ITSKOVITZ-ETAL-1988","unstructured":"Itskovitz, J., Boldes, R., Barlev, A. et al. (1988) The induction of LH surge and oocyte maturation by GnRH analogue (buserelin) in women undergoing ovarian stimulation for in vitro fertilization. Gynecol. Endocrinol., 2, 165."},{"key":"key\n\t\t\t\t20170410034036_ITSKOVITZ-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Itskovitz, J., Boldes, R., Levron, J. et al. (1991) Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil. Steril., 56, 213\u2013220.","DOI":"10.1016\/S0015-0282(16)54474-4"},{"key":"key\n\t\t\t\t20170410034036_ITSKOVITZ-ELDOR-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Itskovitz-Eldor, J., Levron, J. and Kol, S. (1993) Use of GnRH agonists to stimulate ovulation and prevent the ovarian hyperstimulation syndrome. Clin. Obstet. Gynecol., 36, 701\u2013710.","DOI":"10.1097\/00003081-199309000-00026"},{"key":"key\n\t\t\t\t20170410034036_ITSKOVITZ-ELDOR-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Itskovitz-Eldor, J., Kol, S., Mannaerts, B. and Coelingh Bennink, H. (1998) Case report: first established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and gonadotrophin-releasing hormone antagonist ganirelix (Org 37462). Hum. Reprod., 13, 294\u2013295.","DOI":"10.1093\/humrep\/13.2.294"},{"key":"key\n\t\t\t\t20170410034036_LANZONE-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Lanzone, A., Fulghesu, A.M., Villa, P. et al. (1994) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. Fertil. Steril., 62, 35\u201341.","DOI":"10.1016\/S0015-0282(16)56812-5"},{"key":"key\n\t\t\t\t20170410034036_LEWIT-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Lewit, N., Kol, S., Manor, D. and Itskovitz-Eldor, J. (1995) The use of GnRH analogs for induction of the preovulatory gonadotropin surge in assisted reproduction and prevention of the ovarian hyperstimulation syndrome. Gynecol. Endocrinol., 4, 13\u201317.","DOI":"10.3109\/09513599509160676"},{"key":"key\n\t\t\t\t20170410034036_LEWIT-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Lewit, N., Kol, S., Manor, D. and Itskovitz-Eldor, J. (1996) Comparison of GnRH analogs and HCG for the induction of ovulation and prevention of ovarian hyperstimulation syndrome (OHSS): a case-control study. Hum. Reprod., 11, 1399\u20131402.","DOI":"10.1093\/oxfordjournals.humrep.a019407"},{"key":"key\n\t\t\t\t20170410034036_OLIVENNES-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Olivennes, F., Fanchin, R., Bouchard, P. et al. (1996) Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist. Fertil. Steril., 66, 151\u2013153.","DOI":"10.1016\/S0015-0282(16)58404-0"},{"key":"key\n\t\t\t\t20170410034036_SEGAL-AND-CASPER-1992","doi-asserted-by":"crossref","unstructured":"Segal, S.and Casper, R.F. (1992) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertil. Steril., 57, 1254\u20131258.","DOI":"10.1016\/S0015-0282(16)55083-3"},{"key":"key\n\t\t\t\t20170410034036_YEN-ETAL-1968","doi-asserted-by":"crossref","unstructured":"Yen, S.S.C., Lenera, G., Little, B. and Pearson, O.H. (1968) Disappearance rate of endogenous luteinizing hormone and chorionic gonadotropin in man. J. Clin. Endocrinol. Metab., 28, 1763\u20131767.","DOI":"10.1210\/jcem-28-12-1763"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T07:13:14Z","timestamp":1497510794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/15.9.1965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2000,9]]},"published-print":{"date-parts":[[2000,9]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/15.9.1965","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}